• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

教育年限和年龄对墨西哥携带该突变的临床前携带者的CERAD-MX表现的影响:随机数据模拟

The effect of years of schooling and age on CERAD-MX performance in Mexican preclinical carriers of the mutation: Randomized data simulation.

作者信息

Zuno-Reyes Angélica, Pérez-Rubio Karina, Flores-González Martín Alonso, Torres Ricardo Jauregui, Dumois-Petersen Sofía, Figuera Luis E, Ringman John M, Matute Esmeralda

机构信息

Instituto de Neurociencias CUCBA Universidad de Guadalajara Jalisco México.

Centro de Investigación en Matemáticas, CIMAT Guanajuato México.

出版信息

Alzheimers Dement (Amst). 2024 Aug 21;16(3):e12631. doi: 10.1002/dad2.12631. eCollection 2024 Jul-Sep.

DOI:10.1002/dad2.12631
PMID:39170093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11336201/
Abstract

INTRODUCTION

We aimed to determine the effect of years of schooling (YoS) and age on the Mexican adaptation of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD-MX) scores in preclinical carriers group (PCG) and non-carriers group (NCG) of the mutation.

METHODS

We included 39 first-degree Mexican relatives of carriers (PCG = 15; NCG = 24). We report eight CERAD-MX tasks: Mini-Mental State Examination (MMSE), Word List Learning (WLL), Delayed Recall (WLD) and Recognition (WLR), Constructional Praxis Copy (CPC) and Recall (CPR), Semantic Verbal Fluency (SVF), and Verbal Boston Naming (VBN), comparing both groups' performance and simulating new samples' random vectors by inverse transform sampling.

RESULTS

PCG and NCG performed similarly on CERAD-MX. In both groups, YoS and age influence all scores. A positive age effect resulted for PCG on CPC and SVF; for the NCG on MMSE, SVF, and VBN.

DISCUSSION

All tasks are influenced by YoS. Higher YoS/younger age or YoS/older age interactions affected different tasks, suggesting that YoS confounds outcomes.

HIGHLIGHTS

Years of schooling (YoS) and age affect the Mexican adaptation of the Consortium to Establish a Registry for Alzheimer's Disease scores of preclinical carriers.Preclinical carriers underperformed non-carriers on Constructional Praxis Recall.Fewer YoS emerges as a confounding variable when detecting cognitive failures.Younger participants in both groups overperformed the older ones in the Memory tasks.Randomized data simulation increases statistical power when analyzing rare diseases.

摘要

引言

我们旨在确定受教育年限(YoS)和年龄对携带突变的临床前携带者组(PCG)和非携带者组(NCG)中阿尔茨海默病注册协会墨西哥版(CERAD - MX)评分的影响。

方法

我们纳入了39名携带突变者的墨西哥一级亲属(PCG = 15;NCG = 24)。我们报告了八项CERAD - MX任务:简易精神状态检查表(MMSE)、单词表学习(WLL)、延迟回忆(WLD)和识别(WLR)、临摹结构实践(CPC)和回忆(CPR)、语义言语流畅性(SVF)以及言语波士顿命名(VBN),比较了两组的表现,并通过逆变换抽样模拟新样本的随机向量。

结果

PCG和NCG在CERAD - MX上表现相似。在两组中,YoS和年龄影响所有评分。年龄对PCG的CPC和SVF有正向影响;对NCG的MMSE、SVF和VBN有正向影响。

讨论

所有任务都受YoS影响。较高的YoS/较年轻年龄或YoS/较年长年龄的相互作用影响不同任务,表明YoS混淆了结果。

要点

受教育年限(YoS)和年龄影响阿尔茨海默病注册协会墨西哥版对携带突变的临床前携带者评分。临床前携带者在结构实践回忆方面表现不如非携带者。在检测认知失误时,较少的YoS成为一个混杂变量。两组中较年轻的参与者在记忆任务中的表现优于较年长的参与者。在分析罕见疾病时,随机数据模拟可提高统计效力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd48/11336201/bc294323eda1/DAD2-16-e12631-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd48/11336201/cec08871fa3e/DAD2-16-e12631-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd48/11336201/bc294323eda1/DAD2-16-e12631-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd48/11336201/cec08871fa3e/DAD2-16-e12631-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd48/11336201/bc294323eda1/DAD2-16-e12631-g001.jpg

相似文献

1
The effect of years of schooling and age on CERAD-MX performance in Mexican preclinical carriers of the mutation: Randomized data simulation.教育年限和年龄对墨西哥携带该突变的临床前携带者的CERAD-MX表现的影响:随机数据模拟
Alzheimers Dement (Amst). 2024 Aug 21;16(3):e12631. doi: 10.1002/dad2.12631. eCollection 2024 Jul-Sep.
2
Linear and Nonlinear Effect of Years of Schooling, Sex, and Age on the CERAD-MX and Complementary Tasks in a Mexican Sample: A Cross-Sectional Study.受教育年限、性别和年龄对 CERAD-MX 及补充任务的线性和非线性影响:一项墨西哥样本的横断面研究。
Arch Clin Neuropsychol. 2023 Aug 24;38(6):962-975. doi: 10.1093/arclin/acad009.
3
The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.阿尔茨海默病预防计划综合认知测试分数:早老素1 E280A突变携带者中用于评估临床前阿尔茨海默病治疗的样本量估计
J Clin Psychiatry. 2014 Jun;75(6):652-60. doi: 10.4088/JCP.13m08927.
4
The impact of the CERAD-NP on diagnosis of cognitive deficiencies in late onset depression and Alzheimer's disease.CERAD-NP对晚发性抑郁症和阿尔茨海默病认知缺陷诊断的影响。
Int J Geriatr Psychiatry. 2006 Oct;21(10):911-6. doi: 10.1002/gps.1579.
5
Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker Study.检查常染色体显性阿尔茨海默病认知和神经退行性变标志物的性别差异:来自哥伦比亚阿尔茨海默病预防倡议生物标志物研究的初步发现。
J Alzheimers Dis. 2020;77(4):1743-1753. doi: 10.3233/JAD-200723.
6
Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.常染色体显性阿尔茨海默病的神经影像学和临床标志物的纵向评估:一项前瞻性队列研究。
Lancet Neurol. 2015 Aug;14(8):804-813. doi: 10.1016/S1474-4422(15)00135-0. Epub 2015 Jun 29.
7
The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.参与阿尔茨海默病注册协会(CERAD)研究的阿尔茨海默病患者锥体外系症状与认知表现之间的关系。阿尔茨海默病注册协会。
Neurology. 1997 Jul;49(1):70-5. doi: 10.1212/wnl.49.1.70.
8
In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.在泰国人群中,载脂蛋白 E4 等位基因影响神经心理学、生物行为和社会功能的多个领域,从而导致阿尔茨海默病,而载脂蛋白 E3 等位基因则可预防神经精神症状和社会心理缺陷。
Mol Neurobiol. 2018 Aug;55(8):6449-6462. doi: 10.1007/s12035-017-0848-0. Epub 2018 Jan 6.
9
CERAD test performance and cognitive impairment in Parkinson's disease.CERAD 测试在帕金森病中的表现与认知障碍。
Acta Neurol Scand. 2013 Dec;128(6):409-13. doi: 10.1111/ane.12138. Epub 2013 May 14.
10
Cognitive evaluation of patients with glaucoma and its comparison with individuals with Alzheimer's disease.青光眼患者的认知评估及其与阿尔茨海默病患者的比较。
Int Ophthalmol. 2018 Oct;38(5):1839-1844. doi: 10.1007/s10792-017-0658-4. Epub 2017 Jul 25.

本文引用的文献

1
Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimer's disease.载脂蛋白基因型和受教育程度对常染色体显性阿尔茨海默病认知功能的影响。
Nat Commun. 2023 Aug 23;14(1):5120. doi: 10.1038/s41467-023-40775-z.
2
CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting.CERAD(阿尔茨海默病研究联盟)神经心理学评估工具包:35 年的历程与展望。
J Alzheimers Dis. 2023;93(1):1-27. doi: 10.3233/JAD-230026.
3
Alzheimer's Disease: An Updated Overview of Its Genetics.
阿尔茨海默病:遗传学的最新综述。
Int J Mol Sci. 2023 Feb 13;24(4):3754. doi: 10.3390/ijms24043754.
4
Linear and Nonlinear Effect of Years of Schooling, Sex, and Age on the CERAD-MX and Complementary Tasks in a Mexican Sample: A Cross-Sectional Study.受教育年限、性别和年龄对 CERAD-MX 及补充任务的线性和非线性影响:一项墨西哥样本的横断面研究。
Arch Clin Neuropsychol. 2023 Aug 24;38(6):962-975. doi: 10.1093/arclin/acad009.
5
Attitudes about involvement in hypothetical clinical trial protocols in Mexican and Mexican-American at risk for autosomal dominant Alzheimer's disease.墨西哥裔和墨西哥裔美国人对参与假设性临床试验方案的态度,这些人有常染色体显性阿尔茨海默病的风险。
Alzheimers Res Ther. 2022 Nov 15;14(1):173. doi: 10.1186/s13195-022-01114-4.
6
How can secondary dementia prevention trials of Alzheimer's disease be clinically meaningful?阿尔茨海默病的二级痴呆预防试验如何具有临床意义?
Alzheimers Dement. 2023 Mar;19(3):1073-1085. doi: 10.1002/alz.12788. Epub 2022 Sep 26.
7
Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease.为何临床试验与结局测量同等重要:阿尔茨海默病临床试验中认知结局测量选择和使用的框架。
Alzheimers Dement. 2023 Feb;19(2):708-720. doi: 10.1002/alz.12773. Epub 2022 Sep 10.
8
Effect of Social Determinants of Health on Cognition and Risk of Alzheimer Disease and Related Dementias.健康的社会决定因素对认知及阿尔茨海默病和相关痴呆症风险的影响。
Clin Ther. 2021 Jun;43(6):922-929. doi: 10.1016/j.clinthera.2021.05.005. Epub 2021 Jun 5.
9
Disease duration in autosomal dominant familial Alzheimer disease: A survival analysis.常染色体显性遗传性家族性阿尔茨海默病的病程:一项生存分析。
Neurol Genet. 2020 Aug 18;6(5):e507. doi: 10.1212/NXG.0000000000000507. eCollection 2020 Oct.
10
Predicting educational achievement from genomic measures and socioeconomic status.从基因组测量和社会经济地位预测教育成就。
Dev Sci. 2020 May;23(3):e12925. doi: 10.1111/desc.12925. Epub 2019 Dec 18.